DIAアカウントをお持ちの場合、サインインしてください。

サインイン

ユーザーIDをお忘れですか? or パスワードをお忘れですか?

Novotel Mumbai Juhu Beach

2024年9月24日 (火) 午前 8:00 - 2024年9月25日 (水) 午後 6:00

Balraj Sahni Marg, Juhu Beach, Mumbai 400049, India

DIA India Annual Meeting 2024

Confluence of Care: Pharmacovigilance, Clinical Innovation, Regulatory Sciences, and Medical Devices Elevating Patient Safety

Track 3 Session 2: Clinical Evidence for Medical Devices

Session Chair(s)

Ashish  Indani

Ashish Indani

Senior Manager – Clinical Affairs Neurovascular

Stryker Global Technology Center, India

Clinical Evidence for Medical Devices is regarded as one of the most revolutionary aspects of its entire lifecycle, involving numerous stakeholders. Unlike drugs, clinical evidence requirement for medical devices is not straightforward or systematic and is even discretional to some extent. In this session, the expertise of industry speakers will help you comprehend the optimal extent and method for Clinical Evidence of Medical Devices.

Speaker(s)

Debashis  Das

How Much And What Clinical Evidence Is Sufficient For Medical Devices?

Debashis Das

Medtronic, India

Medical/Clinical Affairs, Training & Education Leader - APAC

Srirupa  Das

Dialogue: General Safety And Performance Requirements Vs. Essential Principles – What Should Be The Focus Of The CER?

Srirupa Das

Johnson & Johnson Private Limited, India

Country Medical Director

Siddharth  Jain

With Additional Participation Of:

Siddharth Jain

Symbiorph Clinical Trialogy, India

CEO and Medical Device Regulatory Advisor

Ashokkumar  Thakkar

Contributing Panelist

Ashokkumar Thakkar

Meril Life Sciences Pvt. Ltd., India

Head of Clinical Research

最新情報や機会を逃さないで

DIAのメールを購読すれば、常に最新の業界情報やイベント情報を得ることができます。